Status:
COMPLETED
Burden of Ischemic Stroke and Intake of Oral Anticoagulants in Patients With Atrial Fibrillation in the UK Primary Care
Lead Sponsor:
Bayer
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
20-89 years
Brief Summary
This study will characterize patients with ischemic stroke, a condition which occurs when a vessel supplying blood to the brain is obstructed, and a subpopulation of patients with irregular and often ...
Detailed Description
The primary objectives of the study are to determine the incidence of ischemic stroke in patients registered in the British primary care THIN database and to investigate the OAC exposure, OAC treatmen...
Eligibility Criteria
Inclusion
- Occurrence of an ischemic stroke that lead to hospitalization between 01-Jul-2016 to 30-Jun-2018 and concerned adults registered in the THIN database
- Subgroup: Patients with diagnosed NVAF prior or at the time of ischemic stroke
Exclusion
- None
Key Trial Info
Start Date :
October 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 16 2020
Estimated Enrollment :
3739 Patients enrolled
Trial Details
Trial ID
NCT04099238
Start Date
October 1 2019
End Date
July 16 2020
Last Update
April 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many facilities
Multiple Locations, United Kingdom